Skip to main content
. 2012 Jun;53(3):207–210. doi: 10.3325/cmj.2012.53.207

Figure 1.

Figure 1

Disability (light gray) and mortality (dark gray) contribution to the total disease burden for selected diseases in Europe (WHO subregion EUR A). Source: Kobelt G, Kasteng F. Access to innovative treatments in rheumatoid arthritis in Europe, reproduced with permission from The Pharmaceutical Industry in Figures, EFPIA, 2010 edition (2).